Gersl V
Dptm. of Pharmacology, Hradec Králové.
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 1992;35(4):327-36.
The effects of i. v. administration of Na2H2EDTA and a novel chelator MgNa2EDTA (both drugs in doses of 0.05 and 0.1 mg. kg-1) on the left ventricular dP/dtmax. of the paced and non-paced heart were investigated in rabbits in vivo. Both chelators induced a decrease in cardiac contractility which was, especially after the lower doses of the drugs, significantly less pronounced after MgNa2EDTA (max. 69.6% in the non-paced and 75.2% in the paced heart) in comparison with Na2H2EDTA (max. 51.3% in the non-paced and 52.9% in the paced heart). The decrease in dP/dtmax. was similar both under the paced and non-paced heart conditions after administration of both doses of the drugs. On the basis of the results obtained, it is possible to assume that the negative inotropic effects of the new chelator MgNa2EDTA may be lower in comparison with those of Na2H2EDTA and that cardiac pacing does not influence the inotropic response to the chelators in a negative manner. Premature deaths of a number of animals after the administration of both chelators show a necessity of further studies concerning especially cardiac intracellular ion concentrations.
在兔体内研究了静脉注射乙二胺四乙酸二钠(Na2H2EDTA)和新型螯合剂乙二胺四乙酸镁二钠(MgNa2EDTA)(两种药物剂量均为0.05和0.1mg·kg-1)对起搏和非起搏心脏左心室最大dp/dt的影响。两种螯合剂均引起心脏收缩力下降,尤其是在较低剂量药物作用后,与乙二胺四乙酸二钠相比,乙二胺四乙酸镁二钠引起的心脏收缩力下降明显较轻(非起搏心脏中最大下降69.6%,起搏心脏中最大下降75.2%),而乙二胺四乙酸二钠(非起搏心脏中最大下降51.3%,起搏心脏中最大下降52.9%)。在给予两种剂量药物后,无论是在起搏还是非起搏心脏条件下,dp/dtmax的下降情况相似。根据所得结果,可以推测新型螯合剂乙二胺四乙酸镁二钠的负性肌力作用可能比乙二胺四乙酸二钠低,并且心脏起搏不会对螯合剂的肌力反应产生负面影响。在给予两种螯合剂后,许多动物过早死亡,这表明有必要进一步研究,特别是关于心脏细胞内离子浓度的研究。